Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000027.xml
Download PDF
intensiv 2019; 27(03): 153-155
DOI: 10.1055/a-0873-0348
DOI: 10.1055/a-0873-0348
CNE Schwerpunkt
Update Sepsis
SAPF – eine seltene, aber schwere Komplikation
Authors
Further Information
Publication History
Publication Date:
07 May 2019 (online)
Zusammenfassung
Von der Sepsis-assoziierten Purpura fulminans sind überwiegend Kinder zwischen einem und drei Jahren und Jugendliche zwischen 16 und 18 Jahren betroffen. Eine frühe Diagnose ist auch deswegen so wichtig, damit die Wahrscheinlichkeit einer Amputation so gering wie möglich gehalten wird.
-
Literatur
- 1 Nicolas P, Debonne JM. Infections à méningocoques. Maladies infectieuses. 2002
- 2 European Commission. Rare diseases – what are they?. 2018 Online unter bit.ly/2U2P8X5 letzter Zugriff 05.03.2019
- 3 Veldman A, Fischer D, Wong FY. et al. Human protein C concentrate in the treatment of Purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients. Crit Care 2010; 14 (04) R156
- 4 Contou D, Sonneville R, Canoui-Poitrine F. et al. Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study. Intensive Care Med 2018; 44 (09) 1502-11
- 5 Guelliot A. Note sur trois cas de purpusa infectieux foudroyant. Un Med Sci Nord-Est 1884; 8: 25
- 6 Waterhouse R. A case of suprarenal apoplexy. The Lancet 177 (4566) 577-8
- 7 Chalmers E, Cooper P, Forman K. et al. Purpura fulminans: recognition, diagnosis and management. Arch Dis Child 2011; 96 (11) 1066-71
- 8 Darmstadt GL. Acute infectious Purpura fulminans: pathogenesis and medical management. Pediatr Dermatol 1998; 15 (03) 169-83
- 9 Warner PM, Kagan RJ, Yakuboff KP. et al. Current management of Purpura fulminans: a multicenter study. J Burn Care Rehabil 2003; 24 (03) 119-26
- 10 Thomsen RW, Schoonen WM, Farkas DK. et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med 2009; 151 (08) 546-55
- 11 Bisharat N, Omari H, Lavi I. et al. Risk of infection and death among post-splenectomy patients. J Infect 2001; 43 (03) 182-6
- 12 Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991; 78 (09) 1031-8
- 13 Foss Abrahamsen A, Hoiby EA, Hannisdal E. et al. Systemic pneumococcal disease after staging splenectomy for Hodgkin’s disease 1969–1980 without pneumococcal vaccine protection: a follow-up study 1994. Eur J Haematol 1997; 58 (02) 73-7
- 14 Kyaw MH, Holmes EM, Toolis F. et al. Evaluation of severe infection and survival after splenectomy. Am J Med 2006; 119 (03) 276.e1-7
- 15 Ejstrud P, Kristensen B, Hansen JB. et al. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis 2000; 32 (05) 521-5
- 16 Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Robert Koch-Institut; 2015